创美药业2025中期报告

關於我們 創美藥業股份有限公司（「本公司」或「我們」，連同其附屬公司，統稱「本集團」）（股份代號：2289.HK）主營醫藥分銷業務，主要向下游分銷商和零售終端分銷西藥、中成藥、保健品等產品，同時也開展第三方物流服務，並提供醫藥產品諮詢服務。本公司創立於2000年，經過25年的快速發展，已成長為華南地區領先的醫藥分 銷 商 之 一 。 本 公 司 堅 持 「 深 耕 廣東，輻射周邊」的發展戰略，立足於汕頭，在廣州、珠海、惠州、佛山及深圳成立子公司，並擁有四個現代化醫藥物流中心，專業的營銷服務團隊以及運輸服務團隊，對非招標市場實行「半徑10公里內一日三配、50公里內一日兩配、250公里內一日一配」的高效配送機制。本公司具有現代化信息系統，涵蓋整個醫藥分銷供應鏈，包括採購、銷售、倉儲、運輸及交付等。本公司同時運營自建的B2B電子商務平台：「創美e藥」，供客戶線上下單、查詢及支付等。本公司於2024年全國批發企業主營業務收入前100位排序34。本公司於廣東省醫藥流通企業排名第6位。 Charmacy Pharmaceutical Co., Ltd. (the “Company” or “we”,together with its subsidiaries, collectively, the “Group”) (stockcode:2289.HK)is principally engaged in the pharmaceuticaldistributionbusiness.It mainly distributes western medicine,Chinese patent medicine and healthcare products to downstreamdistributors and retail terminals,while conducting dealings in thethird-party logistics business of medicines and providingpharmaceutical products related consulting services. Founded in2000, over the past 25years of rapid development, it has becomeone of the leading pharmaceutical distributors in the SouthernChinaregion. The Company adheres to the development strategy of“IntensiveEngagement in Guangdong Province and ExtensiveCoverage across Surrounding Areas”, based in Shantou, it hasestablished subsidiaries in Guangzhou, Zhuhai, Huizhou, FoshanandShenzhen,and has four modern pharmaceutical logisticscenters., all equipped with Professional marketing service team,professional transportation teams, and has a highly efficient deliverymechanism of delivering pharmaceutical products three times perdayfor customers within a radius of 10 kilometers, twice per day forcustomers within a radius of 50 kilometers and once per day forthose within a radius of 250 kilometers. In addition, the Companyhas a modern information system that covers the entire supply chainforpharmaceutical distribution,including procurement,sales,warehousing, transportation and delivery. Apart from that, theCompany operates its own B2B e-commerce platform “Charmacye-Medicine” (創美e藥), a platform for customers to place ordersonline, make inquires and payment, etc. In2024, the Companyranked top34among top 100 the PRC wholesalers, in respect ofrevenuegenerated from the principal business. The Companyranked the 6th among the pharmaceutical distribution businesses inGuangdong Province. In the first half of 2025,the Groupcontinued to strengthen itstechnical capabilities and service levelsin pharmaceutical logistics,receivingthe“Best Logistics Centre for Pharmaceutical ColdChain”(for seven consecutive years),the“RecommendedEnterprise for Pharmaceutical Cold Chain Logistics Services” (forsixconsecutiveyears),the“OutstandingEnterpriseinPharmaceutical Logistics Distribution” (for five consecutive years),and the “Modern Pharmaceutical Logistics Technology TestingBase”(for four consecutive years)from the YaolianquanCertification Center for 2024–2025. We also received the “GoldenAnt Innovation Award in China’s Logistics Industry” for 2024–2025from the Organising Committee of the LET-a CeMAT ASIA event(foreight consecutive year).Furthermore,in response to the“Enterprise Standards Forerunner” initiative jointly launched by theStateAdministration for Market Regulation and seven othergovernment departments, and following a rigorous assessment bythe China Federation of Logistics & Purchasing, we were honoredwith the “Forerunner” title for 2024. 2025年上半年，本集團在醫藥物流領域持續提升技術實力和服務水平，獲得藥鏈圈認證中心頒發的2024-2025年度之「醫藥冷鏈最佳物流中心」（連續7年獲得）、「醫藥冷鏈物流服務推薦企業」（連續6年獲得）、「醫藥物流配送優秀企業」（連續5年獲得）、「現代醫藥物流技術試驗基地」（連續4年獲得）；中國（廣州）國際物流裝備與技術展會組委會授予的2024-2025年度「中國物流行業金螞蟻創新獎」（連續8年獲得）；我們積極響應市場監 管 總 局 等 八 部 門 推 行 的 企 業 標 準「領跑者」制度，經中國物流與採購聯合會嚴格評審，成功獲得2024年度「領跑者」稱號。 目錄 公司資料Corporate Information1 財務摘要Financial Summary4 管理層討論及分析Management Discussion and Analysis5 其他資料Other Information 29 36 52 公司資料 *董事 *DIRECTORS 執行董事 Executive Directors 姚創龍(董事會副主席)鄭玉燕張寒孜 Yao Chuanglong (Vice-chairman of the Board) Zheng Yuyan Zhang Hanzi 非執行董事 Non-executive Directors Yan Jingbin (Chairman of the Board) Fu Zheng Xu Fei 獨立非執行董事 Independent non-executive Directors 李漢國尹智偉關鍵（又稱關蘇哲） Li HanguoWan Chi Wai AnthonyGuan Jian (also known as Guan Suzhe) *SUPERVISORS *監事 朱明洪張玲鄭禧玥 Zhu MinghongZhang LingZheng Xiyue *聯席公司秘書 *JOINT COMPANY SECRETARIES 黃慧玲姚潔晞 *審核委員會 *AUDIT COMMITTEE Wan Chi Wai Anthony (Chairman) *NOMINATION COMMITTEE（Note） *提名委員會（註） 關鍵（主席）鄭玉燕李漢國 Guan Jian (Chairman)Zheng YuyanLi Hanguo *薪酬委員會 *REMUNERATION COMMITTEE 李漢國（主席）付征尹智偉 Li Hanguo (Chairman)Fu ZhengWan Chi Wai Anthony *風險管理委員會 *RISK MANAGEMENT COMMITTEE 姚創龍（主席）張寒孜李漢國 Yao Chuanglong (Chairman)Zhang HanziLi Hanguo *戰略發展委員會 *STRATEGIC DEVELOPMENT COMMITTEE 嚴京斌（主席）姚創龍鄭玉燕 Yan Jingbin (Chairman)Yao ChuanglongZheng Yuyan *授權代表 * AUTHORISED REPRESENTATIVES 鄭玉燕姚潔晞 Yao Jiexi *核數師 * AUDITOR 信永中和會計師事務所（特殊普通合夥） ShineWingCertified Public Accountants(Special GeneralPartnership) *法律顧問 * LEGAL ADVISERS DeHeng Law Offices (Hong Kong) LLP (as to Hong Kong laws) 德恒律師事務所（香港）有限法律責任合夥（香港法律） 廣東信